Price
Frequently asked questions
What is Sernova's market capitalization?
What is the Earnings Per Share (EPS) for Sernova?
What are the analyst ratings and target price for Sernova's stock?
What is the EBITDA for Sernova?
What is the free cash flow of Sernova?
What is the 5-year beta of Sernova's stock?
What is the free float of Sernova's shares?
Financials
Market Cap
$54.68M5Y beta
1.29EPS (TTM)
-$0.0918Free Float
285.85MEBITDA (TTM)
-$27.39MFree Cashflow (TTM)
-$18.83MPricing
Analyst Ratings
The price target is $2.515 and the stock is covered by 6 analysts.
Buy
5
Hold
1
Sell
0
Information
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker